Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-EN Version v8-EN
Language English English
Date Updated 2017-10-07 2017-10-06
Drug Identification Number 02245977 02245977
Brand name RECOMBIVAX HB -(ADULT DIALYSIS-PRESERVATIVE FREE) RECOMBIVAX HB -(ADULT DIALYSIS-PRESERVATIVE FREE)
Common or Proper name (hepatitis B vaccine [recombinant]) (hepatitis B vaccine [recombinant])
Company Name MERCK CANADA INC MERCK CANADA INC
Ingredients HEPATITIS B SURFACE ANTIGEN HEPATITIS B SURFACE ANTIGEN
Strength(s) 40MCG 40MCG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 40MCG/1ML 1DOSE VIAL 40MCG/1ML 1DOSE VIAL
ATC code J07BC J07BC
ATC description VIRAL VACCINES VIRAL VACCINES
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2017-10-06 2017-10-06
Actual start date 2017-10-03 2017-10-03
Estimated end date 2017-10-30 2017-10-30
Actual end date 2017-10-06 2017-10-06
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments